The Indian pharmaceutical industry is at the center stage in the global healthcare arena and Ranbaxy endeavors to be at the forefront in delivering the India centric advantages to the advanced and developing countries of the world.
From a small domestic company at inception, Ranbaxy has grown formidably to be a Billion dollar institution that was envisioned by Late Dr Parvinder Singh, Chairman and Managing Director, Ranbaxy in early 90's.
It is with the unwavering ' dedication ' and the ' will to win ' of Team Ranbaxy across the globe that it has traversed this journey so far.
Whilst it continues to enhance the momentum of its generics business in key geographies, parallel to that it is also accelerating its drug discovery program. Ranbaxy is committed to provide quality generics at affordable prices to the patients worldwide with a view to help bring down the healthcare costs. It is confident that its efforts would see the Company emerge as a leading player in the global generic space in the years to come.
As Ranbaxy moves ahead towards its mission to become a Research based International Pharmaceutical Company. It believes it is the spirit of Team Ranbaxy that would enable It to reach out to Vision 2012."
Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. It is ranked amongst the top ten generic companies worldwide. The Company has manufacturing operations in 7 countries with a ground presence in 49 countries and its products are available in over 125 countries.
Ranbaxy was incorporated in 1961 and went public in 1973. For the twelve months ended December 31, 2005, the Company's Global Sales were at US $1178 Mn. Overseas markets accounted for 75% of global sales. The